Everest Medicines Ltd. Financial Overview
Everest Medicines Ltd.'s market cap is currently HK$17.33B. The company's EPS TTM is HK$-0.8420306741; its P/E ratio is -22.36; Everest Medicines Ltd. is scheduled to report earnings on August 28, 2025, and the estimated EPS forecast is HK$0.05. See an overview of income statement, balance sheet, and cash flow financials.
